Insights from Bayer’s $1.5 Billion VC Fund | Lucio Iannone, Head of Health Venture Investments (VP) at Leaps by Bayer
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
Longevity and Preventative Focus in Biotech
Jess asks about longevity investing; Lucio discusses definitional challenges, prevention versus treatment, and pragmatic targets like cardiometabolic disease.
Transcript
Play full episode
